Multiple Sclerosis
📧 Sign up to get email alerts when something new happens for Multiple Sclerosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2011-09-07Clinical Trial Update: Effect of Tysabri in Patients With Relapsing-Remitting Multiple Sclerosis: A Follow-up Magnetization Transfer Imaging (MTI) Study
Clinical trial update describing a follow-up magnetization transfer imaging study in relapsing-remitting multiple sclerosis patients treated…
-
CLINICAL_TRIALS trial_result · 2011-09-05Clinical Trial Update: Can Vitamin D Supplementation Prevent Bone Loss in Persons With Multiple Sclerosis [Phase 4]
Phase 4 study evaluating whether Vitamin D supplementation can prevent bone loss in people with multiple sclerosis and osteoporosis. The tri…
-
CLINICAL_TRIALS trial_result · 2011-08-12Clinical Trial Update: Study of Alternative Exercise Therapies for Progressive Multiple Sclerosis (MS) [NA]
A clinical trial evaluating alternative exercise therapies for progressive multiple sclerosis has completed.
-
CLINICAL_TRIALS trial_result · 2011-08-12Clinical Trial Update: Health Behavior Change in Chronic Disease Management [NA]
A clinical trial focusing on health behavior change in chronic disease management for Multiple Sclerosis has completed.
-
CLINICAL_TRIALS trial_result · 2011-08-09Clinical Trial Update: Evaluate the Safe and Effective Use of the Avonex® Single-Use Autoinjector in Multiple Sclerosis Subjects [Phase 3]
Phase 3 clinical trial evaluating the safety and effectiveness of the Avonex single-use autoinjector in people with multiple sclerosis; resu…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2011-08-08Clinical Trial Update: The Effects of Erythropoietin on Clinical Disability and Brain Pathology in Patients With Progressive Multiple Sclerosis [Phase 2]
This Phase 2 clinical trial update investigates the effects of erythropoietin on clinical disability and brain pathology in patients with pr…
-
CLINICAL_TRIALS trial_result · 2011-08-05Clinical Trial Update: Zenapax to Treat Multiple Sclerosis [Phase 2]
A Phase 2 clinical trial evaluating Zenapax for multiple sclerosis has completed.
-
CLINICAL_TRIALS trial_result · 2011-08-04Clinical Trial Update: Safety and Efficacy Study of Oral Fampridine-SR in Patients With Multiple Sclerosis [Phase 2]
Phase 2 safety and efficacy study of oral dalfampridine extended-release (Fampridine-SR) in multiple sclerosis completed, with results poste…
-
CLINICAL_TRIALS trial_result · 2011-07-29Clinical Trial Update: The Effects of Tysabri Treatment on Vaccination Response and Lymphocyte Subsets in Subjects With Relapsing Forms of Multiple Sclerosis [Phase 4]
Phase 4 trial evaluating natalizumab's effects on vaccination response and lymphocyte subsets in relapsing multiple sclerosis; results were …
-
FDA approval · 2011-07-01FDA Approved: GILENYA — Supplemental Application (Novartis Pharmaceuticals Corporation)
The FDA approved a supplemental application for GILENYA (fingolimod hydrochloride) submitted by Novartis Pharmaceuticals Corporation.
-
CLINICAL_TRIALS trial_result · 2011-06-27Clinical Trial Update: Alfuzosin for Voiding Dysfunction in Multiple Sclerosis (MS) [Phase 2, Phase 3]
Phase 2/3 trial of alfuzosin for voiding dysfunction in people with multiple sclerosis was terminated.
-
FDA approval · 2011-06-17FDA Approved: BACLOFEN — Supplemental Application (Upsher-Smith Laboratories, LLC)
The FDA approved Upsher-Smith Laboratories' supplemental application for baclofen, enabling continued availability of this generic product f…
-
CLINICAL_TRIALS trial_result · 2011-06-17Clinical Trial Update: Evaluate the Maintenance of Effect After Long-term Treatment With Sativex® in Subjects With Symptoms of Spasticity Due to Multiple Sclerosis [Phase 3]
Phase 3 trial evaluating long-term maintenance of effect of Sativex in adults with spasticity due to multiple sclerosis; completed with resu…
-
CLINICAL_TRIALS trial_result · 2011-06-10Clinical Trial Update: Cohort Study of Clinically Isolated Syndrome and Early Multiple Sclerosis
A clinical trial update for a cohort study evaluating progression from clinically isolated syndrome to early multiple sclerosis. The current…
-
CLINICAL_TRIALS trial_result · 2011-06-02Clinical Trial Update: Oral Corticotherapy in Megadoses to Treat Multiple Sclerosis During Relapse [Phase 4]
A Phase 4 clinical trial evaluating high-dose oral corticosteroids for treating relapses in multiple sclerosis has completed.
-
CLINICAL_TRIALS trial_result · 2011-05-19Clinical Trial Update: Efficacy of Anti-Tubercular Vaccination in Multiple Sclerosis [Phase 2, Phase 3]
A completed Phase 2/Phase 3 trial evaluated the efficacy of an anti-tubercular vaccine in people with multiple sclerosis.
-
CLINICAL_TRIALS trial_result · 2011-05-19Clinical Trial Update: Colecalciferol as an Add-on Treatment to Interferon-beta-1b for Treatment of Multiple Sclerosis (MS) [Phase 4]
A Phase 4 clinical trial is investigating colecalciferol as an add-on to interferon-beta-1b for multiple sclerosis; the study status is curr…
-
CLINICAL_TRIALS trial_result · 2011-05-16Clinical Trial Update: Efficacy and Safety of Fingolimod in Patients With Relapsing-remitting Multiple Sclerosis With Optional Extension Phase [Phase 3]
A Phase 3 trial assessing fingolimod for relapsing-remitting multiple sclerosis, reporting efficacy and safety with an optional extension ph…
-
CLINICAL_TRIALS trial_result · 2011-05-16Clinical Trial Update: Ambulation Study in Multiple Sclerosis
The ambulation study in multiple sclerosis has completed.
-
CLINICAL_TRIALS trial_result · 2011-05-06Clinical Trial Update: Study of Oral Fampridine-SR in Multiple Sclerosis [Phase 3]
Phase 3 trial results for oral fampridine-SR in multiple sclerosis have been completed with results posted in 2011.
-
FDA approval · 2011-04-26FDA Approved: MITOXANTRONE — Supplemental Application (Fresenius Kabi USA, LLC)
FDA approved a supplemental application for mitoxantrone hydrochloride from Fresenius Kabi USA, LLC. This approval encompasses the generic p…
-
CLINICAL_TRIALS research · 2011-04-25Clinical Trial Update: Evaluating Alemtuzumab as a Treatment in Stabilizing Neurocognitive Function In Relapsing Remitting Multiple Sclerosis Patients [Phase 3]
This entry provides an update on a Phase 3 clinical trial evaluating alemtuzumab for stabilizing neurocognitive function in relapsing-remitt…
-
CLINICAL_TRIALS trial_result · 2011-04-20Clinical Trial Update: Supported Treadmill Training for Progressive Multiple Sclerosis [NA]
A completed clinical trial evaluating the effects of supported treadmill training for individuals with progressive multiple sclerosis.
-
CLINICAL_TRIALS trial_result · 2011-04-14Clinical Trial Update: Study of Fampridine-SR Tablets in Multiple Sclerosis Patients [Phase 3]
A Phase 3 study of dalfampridine extended-release (Fampridine-SR) tablets in patients with multiple sclerosis has completed. Results have be…
-
CLINICAL_TRIALS research · 2011-04-12Clinical Trial Update: A Study to Evaluate Readiness to Self-inject on Adherence and Compliance to Copaxone® Therapy
A completed study evaluating readiness to self-inject and adherence to Copaxone therapy in people with multiple sclerosis.